Vanda Pharmaceuticals Inc.
For the period ended Dec 30, 2025. Filed Dec 31, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Dec 30, 2025 · Filed Dec 31, 2025
Use the contents to explore the available documents and sections.
VNDA$3.82+6.4%Stored close · as of Nov 6, 2026
Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: | December 30, 2025 | VANDA PHARMACEUTICALS INC. | |
|---|---|---|---|
| By: | /s/ Timothy Williams | ||
| Name: | Timothy Williams | ||
| Title: | Senior Vice President, General Counsel and Secretary | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.